MedTrace Logo

Losartan and HCTZ and Amlodipine vs Atenolol and Amlodipine (0954A-309)(COMPLETED)

NCT00140959 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2024-08-15

No results posted yet for this study

Summary

A study to evaluate the effects of combination losartan versus combination atenolol in patients with ambulatory systolic hypertension.

Conditions

Interventions

DRUG

MK0954, losartan potassium/Duration of Treatment: 18 weeks

DRUG

Comparator: losartan, HCTZ, amlodipine, atenolol/Duration of Treatment: 18 weeks

Sponsors & Collaborators

  • Organon and Co

    lead INDUSTRY

Principal Investigators

  • Medical Monitor · Merck Sharp & Dohme LLC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-02-01
Primary Completion
2004-06-30
Completion
2004-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00140959 on ClinicalTrials.gov